On May 4, 2026, at the headquarters hall of Duoc Cuu Long Pharmaceutical Joint Stock Company (DCL), the Announcement and Appointment Ceremony for senior management positions was held in a formal setting, marking an important step in strengthening the Company’s leadership structure and laying the foundation for its next phase of development.
The ceremony was attended by Mr. Nguyen Van Sang – Chairman of the Board of Directors, members of the Group’s Board of Management, and leaders of affiliated subsidiaries. The presence of leadership representatives at all levels reflected the Company’s strong emphasis on human resources as a key factor in its sustainable development strategy.
Speaking at the event, Mr. Nguyen Van Sang emphasized the critical role of the leadership team in driving growth and enhancing organizational capabilities. According to him, appointing the right personnel not only meets operational requirements but also creates momentum for development in an increasingly competitive market environment.
During the ceremony, Duoc Cuu Long officially announced the appointment of Mr. Pham Chung Dinh as Deputy Chief Executive Officer in charge of the Pharmaceutical Market Division. Mr. Dinh possesses many years of experience in the pharmaceutical industry and has previously held senior executive positions in business management. He is highly regarded for his strategic mindset, organizational capabilities, and in-depth understanding of the market.
Ông Phạm Chung Đỉnh – Tân Phó Tổng Giám đốc Kinh doanh phụ trách Khối thị trường Dược phẩm DCL.
The appointment of Mr. Pham Chung Dinh is expected to contribute to improving business performance, expanding market presence, and optimizing management and operational efficiency. In his remarks upon accepting the new role, Mr. Dinh stated that he would work closely with the team to implement solutions aimed at developing the pharmaceutical business in an efficient and sustainable manner.
Continuing the program, the Company also announced the appointment of Mr. Ho Ngoc Dung as Director of Benovas Capsule One Member Limited Liability Company. This leadership consolidation takes place as the Capsule factory transitions to independent operations, with the goal of enhancing operational autonomy and specialization.
Before assuming his new position, Mr. Ho Ngoc Dung made significant contributions as Capsule Sales Director, achieving revenue of VND 320 billion in 2024, representing 12% growth while also expanding the market and maintaining a strong domestic market share. In addition to business achievements, he also played an important role in building the customer network and developing a professional and effective sales team.
Ông Hồ Ngọc Dũng được bổ nhiệm giữ chức vụ Giám đốc Công ty TNHH MTV Benovas Capsule
Speaking after receiving the appointment decision, Mr. Ho Ngoc Dung shared the development orientation for the coming period and expressed his determination to work together with the Benovas Capsule team to maintain the Company’s leading position, improve product quality, and further expand the market.
The ceremony concluded in a formal and optimistic atmosphere. The appointment of these two important leadership positions not only strengthens the organizational structure but also clearly demonstrates the Company’s commitment to placing people at the center of its development strategy.
With the capabilities, experience, and leadership qualities of the newly appointed executives, Duoc Cuu Long is entering a promising stage of stronger growth, enhanced competitiveness, and continued efforts to reinforce its position in the domestic pharmaceutical market while gradually expanding its regional presence.
